Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension

Original Article

M.W. Freeman, Y.-D. Halvorsen, W. Marshall, M. Pater, J. Isaacsohn, C. Pearce, B. Murphy, N. Alp, A. Srivastava, D.L. Bhatt, and M.J. Brown

N Engl J Med 2023;388:395-405

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Course opens: 
02/01/2023
Course expires: 
02/02/2025

Available Credit

  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation